Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18387740rdf:typepubmed:Citationlld:pubmed
pubmed-article:18387740lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:18387740lifeskim:mentionsumls-concept:C0034838lld:lifeskim
pubmed-article:18387740lifeskim:mentionsumls-concept:C0025193lld:lifeskim
pubmed-article:18387740lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:18387740pubmed:issue2lld:pubmed
pubmed-article:18387740pubmed:dateCreated2008-4-21lld:pubmed
pubmed-article:18387740pubmed:abstractTextPrevious studies on the effects of serotonin receptor 1A (5-HT1A) gene variation on treatment response in depression revealed inconsistent results with studies pointing towards a detrimental influence of the 5-HT1A-1019G allele on antidepressant treatment response, while others did not discern any involvement of 5-HT1A variants. In order to further delineate the impact of 5-HT1A gene variation on pharmacoresponse in depression over 6 weeks of antidepressant treatment, the influence of the 5-HT1A-1019C/G (rs6295) polymorphism was investigated in 340 Caucasian patients with a Major Depressive Episode (DSM-IV) with particular attention to the subtype of depression (major depression and melancholic depression). Antidepressant treatment response across 5-HT1A-1019C/G genotype groups showed no differences in either Major Depressive Episode or major depression between genotype groups, whereas stratification for the melancholic subtype of depression revealed a significantly worse treatment response as conferred by the -1019CC genotype (p=0.02). The poorer treatment response in melancholic depression could first be detected in week 2 (p=0.03), continuing until week 6 and showing a maximum effect in week 3 (p=0.01). The present study adds to the clarification of the role of 5-HT1A variation in treatment response in major depression by providing preliminary support for poor treatment response mediated by the 5-HT1A-1019C allele repressing 5-HT1A activity specifically in the melancholic subtype of depression.lld:pubmed
pubmed-article:18387740pubmed:languageenglld:pubmed
pubmed-article:18387740pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18387740pubmed:citationSubsetIMlld:pubmed
pubmed-article:18387740pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18387740pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18387740pubmed:statusMEDLINElld:pubmed
pubmed-article:18387740pubmed:monthMaylld:pubmed
pubmed-article:18387740pubmed:issn0304-3940lld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:RoehrsTTlld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:DeckertJJlld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:AroltVVlld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:HohoffCClld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:BauneB TBTlld:pubmed
pubmed-article:18387740pubmed:authorpubmed-author:DomschkeKKlld:pubmed
pubmed-article:18387740pubmed:issnTypePrintlld:pubmed
pubmed-article:18387740pubmed:day9lld:pubmed
pubmed-article:18387740pubmed:volume436lld:pubmed
pubmed-article:18387740pubmed:ownerNLMlld:pubmed
pubmed-article:18387740pubmed:authorsCompleteYlld:pubmed
pubmed-article:18387740pubmed:pagination111-5lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:meshHeadingpubmed-meshheading:18387740...lld:pubmed
pubmed-article:18387740pubmed:year2008lld:pubmed
pubmed-article:18387740pubmed:articleTitleSerotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?lld:pubmed
pubmed-article:18387740pubmed:affiliationDepartment of Psychiatry, School of Medicine, James Cook University, Queensland 4811, Australia. bernhard.baune@jcu.edu.aulld:pubmed
pubmed-article:18387740pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3350entrezgene:pubmedpubmed-article:18387740lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18387740lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18387740lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18387740lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18387740lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18387740lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18387740lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18387740lld:pubmed